About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Pennsylvania | 623 Studies

Clinical Trials Prostate CancerPennsylvania

Prostate Cancer Clinical Trials in Pennsylvania

Find 623 clinical trials for prostate cancer near Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 501-520 of 623 trials

CompletedR115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005848·Cleveland, Ohio and 1 other CompletedA Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesThis is a Phase 1, open-label, multicenter study of continuous oral dosing of AZD4635 administered to patients with advanced solid malignancies.NCT02740985·Fayetteville, Arkansas and 16 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant…NCT06136624·Orange, California and 287 others

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

CompletedMUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate CancerThe purpose of this study is to determine the effectiveness of a drug called Poly-ICLC, also known as HiltonolTM, in boosting the body's immune system's response to an…NCT00374049·Pittsburgh, Pennsylvania

TerminatedA Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCThe purpose of this study is to compare galeterone to enzalutamide in men expressing androgen receptor spice variant-7 mRNA (AR-V7) in metastatic (M1) castrate resistant prostate…NCT02438007·Scottsdale, Arizona and 116 others

SuspendedRadiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyThis phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in…NCT04071236·Duarte, California and 31 others

Active not recruitingAbiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelThis randomized phase II trial studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with…NCT03419234·Fairbanks, Alaska and 671 others

CompletedGoals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer TreatmentRATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment.NCT01018901·Philadelphia, Pennsylvania

CompletedTechnology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET StudyThis trial performs user testing of a mobile-friendly patient history collection and genetic education tool to improve healthcare providers' understanding of prostate cancer…NCT04447703·New York, New York and 4 others

CompletedIxabepilone in Treating Patients With Metastatic Prostate CancerDrugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00087139·Aurora, Colorado and 161 others

CompletedImaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.A prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA) 7.3…NCT04186819·Birmingham, Alabama and 33 others

Not yet recruitingLTFU for All Cell and Gene Therapy StudiesMaster LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy…NCT06194461·Phoenix, Arizona and 24 others

RecruitingLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerThe purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as…NCT05803941·Scottsdale, Arizona and 53 others

CompletedStudy of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)To test the efficacy of CP-751,871 combined with docetaxel and prednisone in the treatment of prostate cancer that is refractory to hormone therapyNCT00313781·Los Angeles, California and 17 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with metastatic…NCT06863272·Los Angeles, California and 81 others

Active not recruitingTesting the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisThis phase I/II trial studies the best dose and side effects of olaparib and how well it works with radium Ra 223 dichloride in treating patients with castration-resistant…NCT03317392·La Jolla, California and 21 others

CompletedFunctional MRI Use in Prostate Radiation Treatment PlanningThis study is being done to evaluate the use of MRI during radiation treatment planning to identify areas of tumor within the prostate to aid in future treatment planning and…NCT01985932·Philadelphia, Pennsylvania

Terminated18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate CancerThis is an interventional, single group assignment, prospective nonrandomized, open label Phase 2 trial designed to evaluate 18F-DCFPyL PET imaging in men diagnosed with prostate…NCT04727736·Pittsburgh, Pennsylvania

Active not recruitingA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCThe purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC)…NCT05884398·Homewood, Alabama and 92 others

PreviousPage 26 of 32Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma